Diligence memo · auto-generated · as of July 2, 2026

Shezlong

Shezlong looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Shezlong operates in Healthtech, based in Africa. Egyptian online mental health platform Shezlong has raised a new round of investment to help it expand its operations in the Middle East and North Africa (MENA) region.

Sub-sector tags: healthtech.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Shezlong has raised $350K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $350K on 2020-06-08.

Most recent recorded round closed around 2020-06-08.

Valuation (modeled)modeled

Provath models Shezlong at approximately $12M (range $219K–$137M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.17× the median modeled value of Pre-Seed Healthtech companies in 2019–2021 (139 peers) — value vs value, same stage and era. Within the normal band (117% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 6.1 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 18% of Healthtech peers (2138 compared).

Modeled value ranks above 36% of those peers.

Closest niche peers: Hey Healthcare, Inc., Levin Eye Care LLC, Miracle Leaf Health Centers, Corp., Merrimac Medical Investors, LLC, nView medical Inc..

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.